JIG-SAW receives U.S. patent approval for the eyesight regeneration project：NEW-VISION technology（software-based cell control technology）in field of regenerative medicine
Professor Hiroshi Tomita, Ph.D., a JIG-SAW Fellow Will Give a Lecture a The Japanese Retinitis Pigmentosa Society (JRPS) Retinochoroidal Degeneration Forum. JIG-SAW’s Initiatives Regarding Sight Regeneration Will Also Be Announced.
We received a patent evaluation for a software-based, cell-controlling eyesight regeneration project NEW-VISION
The efforts of Dr. Tomita, Ph.D. of regenerative medicine, for visual regeneration are reported in the electronic version of Scientific Reports, a publication by the U.K. Nature Publishing Group on January 23, at 10:00 a.m. (GMT) (7:00 p.m. on the same day Japan Time).
JIG-SAW launches regenerative medicine with software-based control of organisms and cells: developing prism glasses for visual regeneration and implanting software to control photoreceptor cells with an aim of helping blind people to regain their sight of light.